Senda Biosciences

About:

Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.

Website: https://www.sendabiosciences.com/

Twitter/X: sendabioscience

Top Investors: Alexandria Venture Investments, Mayo Clinic, Qatar Investment Authority, Stage 1 Ventures, Partners Investment

Description:

Senda Biosciences is a developer of therapeutic applications intended for novel treatments of human disease. The company studies the molecular relationships between bacterial, botanical, and human cells as well as how they define health and disease, providing medical professionals with novel medications and delivery methods. Senda Biosciences was established in 2017 by David Kolesky, Ignacio Martinez, and John Casey in Cambridge, Massachusetts.

Total Funding Amount:

$309M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

press(AT)sendabiosciences.com

Founders:

David Berry, David Kolesky, Ignacio Martinez, John Casey

Number of Employees:

51-100

Last Funding Date:

2022-08-16

IPO Status:

Private

© 2025 bioDAO.ai